Ceballos-Gutiérrez, A.; Rodríguez-Hernández, A.; Álvarez-Valadez, M.d.R.; Limón-Miranda, S.; Andrade, F.; Figueroa-Gutiérrez, A.; Díaz-Reval, I.; Apolinar-Iribe, A.; Castro-Sánchez, L.; Alamilla, J.;
et al. ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure. Nanomaterials 2021, 11, 2319.
https://doi.org/10.3390/nano11092319
AMA Style
Ceballos-Gutiérrez A, Rodríguez-Hernández A, Álvarez-Valadez MdR, Limón-Miranda S, Andrade F, Figueroa-Gutiérrez A, Díaz-Reval I, Apolinar-Iribe A, Castro-Sánchez L, Alamilla J,
et al. ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure. Nanomaterials. 2021; 11(9):2319.
https://doi.org/10.3390/nano11092319
Chicago/Turabian Style
Ceballos-Gutiérrez, Adriana, Alejandrina Rodríguez-Hernández, María del Rosario Álvarez-Valadez, Saraí Limón-Miranda, Felipa Andrade, Alejandro Figueroa-Gutiérrez, Irene Díaz-Reval, Alejandro Apolinar-Iribe, Luis Castro-Sánchez, Javier Alamilla,
and et al. 2021. "ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure" Nanomaterials 11, no. 9: 2319.
https://doi.org/10.3390/nano11092319
APA Style
Ceballos-Gutiérrez, A., Rodríguez-Hernández, A., Álvarez-Valadez, M. d. R., Limón-Miranda, S., Andrade, F., Figueroa-Gutiérrez, A., Díaz-Reval, I., Apolinar-Iribe, A., Castro-Sánchez, L., Alamilla, J., Sánchez-Pastor, E., & Virgen-Ortiz, A.
(2021). ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure. Nanomaterials, 11(9), 2319.
https://doi.org/10.3390/nano11092319
